Objective Ischemic mitral regurgitation (MR) is common, but its response to percutaneous coronary intervention (PCI) is poorly understood. This study tested the utility of myocardial perfusion imaging (MPI) for the stratification of MR response to PCI.
Objective Ischemic mitral regurgitation (MR) is common, but its response to percutaneous coronary intervention (PCI) is poorly understood. This study tested the utility of myocardial perfusion imaging (MPI) for the stratification of MR response to PCI.
Methods MPI and transthoracic echocardiography (echo) were performed among patients undergoing PCI. MPI was used to assess stress/rest myocardial perfusion. MR was assessed via echo (performed before and after PCI).
Results A total of 317 patients with abnormal myocardial perfusion on MPI underwent echo 25 ± 39 days before PCI. MR was present in 52%, among whom 24% had advanced (≥ moderate) MR. MR was found to be associated with left ventricular (LV) chamber dilation on MPI and echo (both P <0.001). The magnitude of global LV perfusion deficits increased in relation to MR severity (P < 0.01). Perfusion differences were greatest for global summed rest scores, which were 1.6-fold higher among patients with advanced MR versus those with mild MR (P = 0.004), and 2.4-fold higher versus those without MR (P < 0.001). In multivariate analysis, advanced MR was found to be associated with a fixed perfusion defect size on MPI [odds ratio 1.16 per segment (confidence interval 1.002-1.34), P = 0.046], independent of LV volume [odds ratio 1.10 per 10 ml (confidence interval 1.04-1.17), P = 0.002]. Follow-up via echo (1.0 ± 0.6 years) demonstrated MR to decrease (≥1 grade) in 31% of patients and increase in 12% of patients. Patients with increased MR after PCI had more severe inferior perfusion defects on baseline MPI (P = 0.028), whereas defects in other distributions and LV volumes were similar (P = NS).
Conclusion
The extent and distribution of single-photon emission computed tomography-evidenced myocardial perfusion defects impact MR response to revascularization. An increased magnitude of inferior fixed perfusion defects predicts post-PCI progression of MR. Coron Artery Dis 26:642-650 Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Introduction
Mitral regurgitation (MR) is present in~20% of patients undergoing coronary revascularization, conferring increased risk for long-term morbidity and mortality [1] [2] [3] . Typically termed 'ischemic MR', this condition has been widely attributed to infarction and ischemia in the left ventricular (LV) myocardium that provides structural and contractile support to the mitral valve [4] [5] [6] . MR response to revascularization is highly variable. In approximately half of the patients, MR improves with surgical revascularization [coronary artery bypass grafting (CABG)], whereas in the remainder, MR persists or worsens [7] [8] [9] [10] [11] . Limited data exist with respect to percutaneous revascularization [percutaneous coronary intervention (PCI)], despite the fact that this is by far the most common means of coronary reperfusion [12] . For example, some studies have shown that MR can improve following PCI alone [13] , whereas others have not [14] . Uncertainty as to which patients with MR will manifest a therapeutic response to coronary revascularization limits the ability to optimize therapeutic strategies for treatment of MR.
Myocardial perfusion imaging (MPI) enables noninvasive assessment of the pattern and severity of altered myocardial perfusion. Myocardial perfusion defects have been associated with the presence and magnitude of MR, stemming from impaired myocardial perfusion in LV segments adjacent to the papillary muscles [15] . MPI has also been shown to predict MR response to CABG, as evidenced by a greater improvement in MR among patients with a more extensive viable myocardium [10] . Conventional indices of LV chamber size and function have been shown to be similar between patients with and those without revascularization-induced improvement in MR [9, 10, 13, 16] , highlighting the need for more accurate indices to predict MR therapeutic response.
This study examined myocardial perfusion as a predictor of MR response to PCI. The goals were two-fold: (i) to identify structural indices conferring increased likelihood of MR among patients undergoing PCI, and (ii) to test whether MR response to PCI varies in relation to the pattern and magnitude of impaired myocardial perfusion.
Methods

Population
The population comprised patients who underwent single-photon emission computed tomography (SPECT) MPI and transthoracic echocardiography (echo) before PCI between 2002 and 2013. SPECT and echo were acquired within 1 week; PCI was performed within 6 months after MPI. To study ischemic MR (as opposed to MR due to other causes), patients referred for invasive angiography in the absence of abnormal perfusion as well as those with MR due to other etiologies (prolapse, rheumatic disease, chordal rupture, endocarditis) or with prior mitral valve surgery (prosthesis, annuloplasty) were excluded.
This study was conducted with the approval of the Weill Cornell Medical College institutional review board.
Imaging protocol
Single-photon emission computed tomography MPI was performed in accordance with a previously described protocol [17, 18] . Thallium-201 (Tl-201; ∼ 3 mCi) or technetium-99m sestamibi (Tc-99m; ∼ 10 mCi) was injected intravenously; baseline (rest) perfusion images were acquired ∼ 10 min after Tl-201 and 60 min after Tc-99m sestamibi injection. After baseline imaging, patients capable of exercise underwent treadmill testing using the Bruce protocol: Tc-99m (∼30 mCi) was intravenously administered at peak stress following achievement of the target heart rate response to exercise (≥85% age-predicted maximum). In patients unable to exercise or achieve adequate heart rate response, pharmacologic protocols were used with either adenosine-based agents or dobutamine. Poststress images were acquired ∼ 30 min after exercise and 1-2 h after pharmacologic stress.
SPECT was performed using a dual-headed scintillation camera system with a low-energy high-resolution collimator. For Tl-201 imaging, photopeaks of 70 and 167 keV were utilized. For Tc-99m imaging, a photopeak of 140 keV was utilized. Stress images were ECG-gated for assessment of contractile function; LV chamber size and ejection fraction were quantitatively measured (Cedars-Sinai AutoQuant; Philips Medical Systems, Andover, Massachusetts, USA). Demographic indices were categorized at time of MPI using a uniform questionnaire; results were confirmed by review of medical records. Results of invasive angiography were reviewed for coronary artery disease (CAD) severity and PCI target. Obstructive CAD was defined using standard criteria for native coronary arteries (≥50% left main, ≥ 70% other major epicardial vessel) [19] or bypass grafts (≥70%).
Echocardiography
Echoes were performed by experienced sonographers using commercially available equipment (e.g. General Electric Vivid-7; GE Healthcare, Little Chalfont, UK; and Philips ie33; Philips Healthcare, Best, Netherlands). Images were acquired in the parasternal view, as well as in the apical two-chamber, three-chamber, and fourchamber orientations. LV ejection fraction and chamber size were quantified using linear dimensions in parasternal views [20] . Color Doppler was used to assess MR severity on the basis of jet area, depth, vena contracta, and directionality. Pulsed-wave Doppler included assessment of MR duration, as well as pulmonary vein flow profiles.
Image analysis Myocardial perfusion
MPI was interpreted by American Heart Association/ American College of Cardiology level III trained readers utilizing a standard 17-segment model [21] . High intraobserver and interobserver reproducibility for MPI interpretation has been reported previously [17] . Visual assessment was confirmed by review of polar plots, with comparison of segmental radiotracer intensity to computer-generated normative datasets. Perfusion defect severity on a per-segment basis was graded using a fivepoint scoring system (0 = normal, 1 = equivocal or mildly reduced, 2 = moderately reduced, 3 = severely reduced, 4 = absent radioisotope uptake) [22] . Summed stress and rest scores were calculated by adding per-segment defect severities for all segments. Summed difference scores were assessed as the difference between rest and stress scores. In accordance with prior studies, a summed stress score of 4 or higher was the criterion for an MPI abnormality (i.e. eligible for study inclusion) [22] .
To test the relation between regional perfusion and MR, established partitions were applied to divide the LV into three equally sized (anterior, inferior, lateral) territories ( Fig. 1 ) [4] . Summed stress, rest, and difference scores in each territory were calculated as the sum of respective perfusion indices within constitutive segments. The presence of perfusion defects in one territory did not preclude classification of perfusion defects in other territories.
Mitral regurgitation
Echoes were interpreted by experienced American Heart Association/American College of Cardiology level III trained readers in a high-volume laboratory, for which methods of measurement of chamber volumes and MR have been previously reported [23] . MR severity was graded on echo using a four-point scale, primarily determined on the basis of the distance reached from the mitral orifice by the regurgitant jet [mild (1 + ), ≤ 0.5 cm; moderate (2 + ), 1.5-3.0 cm; moderate-severe (3 + ), 3.0-4.5 cm; severe (4 + ), ≥ 4.5 cm]. Additional criteria used to confirm MR severity included jet area and vena contracta [(1 + ), color jet < 20% LA area, vena contracta < 0.3; (2 + ), color jet 20-40%, vena contracta 0.3-0.69; (3-4 + ), color jet > 40%, vena contracta ≥ 0.7], jet density, and mitral and pulmonary vein flow pattern [15, 24] .
Follow-up
Echo, when performed for clinical indications, was used to assess MR and LV remodeling in accordance with baseline analytic methods. A minimum of 30 days post-PCI was the criterion for adequate follow-up; maximum follow-up was defined as 2 years post-PCI. Change in MR severity was defined as a difference of at least 1 grade versus baseline (i.e. increased ≥ 1 grade, decreased < 1 grade). Heart rate and blood pressure were obtained noninvasively at baseline (pre-PCI) and at follow-up.
Statistical methods
Comparisons of continuous variables between groups with and without MR were made using Student's t-test for two-group and analysis of variance (ANOVA) for multiple-group comparisons; data for both are expressed as mean values standard deviations. Categorical variables were compared using the χ 2 -test or, when there were fewer than five expected outcomes per cell, Fisher's exact test. Multivariable logistic regression analysis was performed to evaluate the associations between MR and imaging parameters. Two-sided P-values less than 0.05 were considered indicative of statistical significance. Calculations were performed using SPSS Version 20 (IBM, Armonk, New York, USA).
Results
Population characteristics
The population comprised 317 patients without primary mitral valve disease who underwent SPECT MPI and echo within a 1-week (0.6 2.9 day) interval. A total of 14 otherwise eligible patients were excluded based on the presence of echo-evidenced primary mitral valve disease (prolapse n = 8, rheumatic n = 1) or prior mitral surgery (n = 5).
MR was present in half (52%) of the patients (76% mild, 16% moderate, 8% moderate-severe or severe). Table 1 details population characteristics, stratified by the presence or absence of MR. As shown, MR was associated Myocardial perfusion territories. Bullseye plots illustrating regional LV perfusion territories (highlighted). Each category comprised five segments, such that the total myocardium subtended by each was equivalent. LV, left ventricle.
with a clinical history of CAD, including over a 1.5-fold higher prevalence of prior myocardial infarction (MI) among affected patients (P = 0.01). Accordingly, adverse LV remodeling was more advanced among patients with MR, whether measured by global chamber volume on MPI or linear dimensions on echo (both P < 0.001). Figure 2 stratifies MPI volumetric indices in relation to MR severity, demonstrating a stepwise increase in LV dilation and dysfunction from patients with no MR to those with mild MR and advanced (≥ moderate) MR (both P <0.001 for trend). Table 2 compares perfusion indices in relation to the presence and severity of MR. Despite the fact that all patients underwent PCI in the context of abnormal MPI, the magnitude of perfusion abnormalities further stratified the likelihood of MR. Differences between groups were most marked for global summed rest scores, which were 1.6-fold higher among patients with advanced MR versus those with mild MR (P = 0.004), and 2.4-fold higher versus those without MR (P < 0.001). Table 2 also shows that the differences between groups were most marked with respect to inferior perfusion pattern, as evidenced by a greater extent of inferior fixed perfusion deficits among patients with advanced MR versus those with mild (P = 0.004) or no (P = 0.001) MR.
Myocardial perfusion pattern
Multivariate regression analysis (shown in Table 3 ) was used to test the independent association of fixed myocardial perfusion defects with MR after controlling for corresponding clinical indices (history of MI) and adverse geometric remodeling (LV chamber dilation), as can be measured on MPI. Results demonstrated that advanced (≥ moderate) MR was independently associated with the extent of fixed myocardial perfusion defects on MPI, even after controlling for a clinical history of MI and LV chamber volume (Table 3A) . Results were similar when echo-quantified LV chamber diameter was substituted for MPI-quantified end-diastolic volume (Table 3B) , demonstrating that the association between fixed perfusion defects and MR was independent of modality and approach used to measure LV chamber size. For both models, the relationship between MR and LV perfusion deficits showed a graded increase, such that the likelihood for MR increased with a larger size of LV perfusion deficit. Applied clinically, the results indicate that fixed perfusion deficits involving five LV segments would be expected to yield a two-fold increase in the likelihood for MR, independent of the modality used to measure LV chamber size.
Mitral regurgitation response to percutaneous coronary intervention PCI was attempted 24 39 days after MPI. A total of 375 coronary vessels were revascularized in the study population (1.2 0.5 vessels/patient), among whom 24% of the patients underwent multivessel PCI. Table 4 provides a breakdown of CAD anatomy and PCI target vessels. As shown, the prevalence of multivessel CAD increased in relation to the severity of MR (P = 0.025). With regard to PCI, target vessels did not differ between patients with and without MR. As shown, patients with increased MR after PCI had more severe inferior perfusion defects on baseline MPI (P = 0.028), whereas perfusion defects in other distributions, as well as LV chamber volumes, were similar between groups (all P = NS). Among patients with advanced (≥ moderate) MR, follow-up results were similar: inferior perfusion defects on baseline MPI were more severe among patients with increased MR after PCI (8.8 2.6) compared with those with persistent (3.8 3.5) or decreased MR (7.4 4.4) on follow-up (P = 0.03). In multivariate analysis, inferior perfusion defects on baseline MPI were associated with increased MR after PCI [odds ratio 1.2 per segment (confidence interval 1.02-1.39), P = 0.02], independent of follow-up duration [odds ratio 0.99 (confidence interval 0.95-1.03), P = 0.63]. With regard to angiographic parameters, PCI target vessel did not differ between patients with increased MR and the remainder of the cohort, as evidenced by similar rates of left main coronary artery (0 vs. 3%, P = 1.0), left anterior descending artery (40 vs. 50%, P = 0.74), left circumflex artery (50 vs. 36%, P = 0.49), and right coronary artery (20 vs. 30%, P = 0.72) revascularization.
Discussion
This study demonstrates the utility of myocardial perfusion pattern for stratifying the severity of ischemic MR, as well as its response to PCI. Findings obtained in a broad patient cohort undergoing MPI before PCI demonstrate ischemic MR to be strongly associated with the magnitude and severity of fixed LV perfusion defects. The impact of perfusion pattern on MR was independent of LV remodeling, as evidenced by multivariate models demonstrating MR to be associated with the extent of fixed perfusion defects, irrespective of the modality used to measure LV chamber size. With regard to regionality, inferior perfusion defects on MPI differed most markedly between patients with and without MR on echo, including differences with respect to both the inferior summed rest score and the number of fixed inferior segments between patients with advanced MR and those with mild or no MR (all P < 0.01). Perfusion territories are defined in Fig. 1 . Follow-up demonstrated inferior perfusion deficits to influence MR response to revascularization, as evidenced by higher inferior rest perfusion deficits among patients with increased MR after PCI.
This study is the first to examine whether the pattern of impaired myocardial perfusion predicts ischemic MR response to PCI. Our results, which demonstrate MR improvement in 31% of patients, parallel the findings of a recent study in which MR improved in 37% of patients undergoing PCI [13] . Surgical literature has similarly reported marked heterogeneity in MR improvement following surgical revascularization. Prior studies have reported MR to improve in approximately half (42-69%) of patients Obstructive CAD defined using standard criteria for native coronary arteries (≥50% left main, ≥ 70% other major epicardial vessel) [19] , or bypass grafts (≥70%). undergoing CABG alone [7] [8] [9] [10] [11] . Even when mitral annuloplasty is performed adjunctively with CABG, MR recurs in up to 33% of patients at 1 year postoperatively [25] . These data highlight the need to better identify predictors of MR response to therapy, so as to tailor particular therapeutic strategies to treat MR (i.e. revascularization and/or annuloplasty) based on the underlying mechanism of MR and the anticipated likelihood of therapeutic response.
Our observed association between inferior perfusion defects and MR is consistent with prior literature. Inferior wall MI has been recognized as a cause of MR due to geometric distortion within LV segments supporting the papillary muscles [26, 27] . Regional remodeling after inferior or posterior MI has also been linked to MR, due to impaired LV basal rotational mechanics [28] . Among patients with CAD, our group has reported inferior/inferolateral fixed perfusion defects to be associated with MR [15] . These associations may stem from regional differences in coronary anatomy. Angiographic studies have shown that the posteromedial papillary muscle is typically supplied by a single coronary artery, whereas the anterolateral papillary muscle is more frequently perfused by a dual supply [29] .
In this context, CAD involving the posteromedial papillary muscle would be more likely to produce severe ischemia or infarction (manifested as a fixed inferior perfusion defect on SPECT), thereby more commonly resulting in compromised contractile function, altered LV geometry, and MR.
Our analysis included assessment of both size and distribution of altered myocardial perfusion, so as to test the impact of perfusion pattern on ischemic MR. Prior research, which has categorized ischemia and infarction in a binary manner [13] , has not demonstrated an association between altered myocardial tissue properties and MR response to PCIhighlighting the importance of distribution of myocardial injury as a determinant of both magnitude and therapeutic response of MR [4] . Consistent with our observed association between fixed perfusion defect size and worsened MR after PCI, Penicka et al. [10] reported the extent of nonviable myocardium on SPECT to predict persistent MR after CABG. With regard to mechanism, adverse LV remodeling is known to provide a substrate for MR, resulting from altered papillary muscle geometry and impaired contractility of the LV myocardium underlying the mitral valve. Persistent MR after CABG has been associated with adverse remodeling, as evidenced by postoperative increases in LV size and sphericity [30] . Conversely, decreased MR has been linked to decrements in LV size [31] . Myocardial viability is a key determinant of LV remodeling response to both PCI and CABG [32, 33] . Together with our findings, these data support the notion that MR response to revascularization is strongly influenced by myocardial tissue properties, irrespective of whether surgical or percutaneous strategies are used for coronary reperfusion.
It is important to recognize that this study examined patients with abnormal MPI undergoing PCI, to examine the therapeutic response of ischemic MR, and excluded patients in whom MR was attributable to other causes. In this context, the association between ischemia and MR may have been blunted due to the relative uniformity of the population, in that patients without ischemia/viability would not typically be treated via any means of revascularization, whereas those with more severe ischemia would be expected to undergo CABG (rather than PCI). Prior studies have demonstrated a physiologic link between ischemia and MR. Using a canine model, Kono et al. [6] demonstrated that MR could be induced with transient coronary occlusion and relieved with reperfusion. Messas et al. [5] , using a sheep model, demonstrated that inferior ischemia produced MR. The importance of ischemia has also been demonstrated in population-based studies of MR. For example, among a cohort of 2377 participants with known or suspected CAD, our group demonstrated MR to be independently associated with the magnitude of both inducible (i.e. ischemic) and fixed perfusion defects on SPECT MPI [15] .
Several limitations should be noted. First, it is important to recognize that this study did not use a uniform quantitative method to measure MR, but instead applied a semiquantitative grading system, as has been used in prior research [15, 23] , including a recent multicenter study of MR response to therapeutic interventions [25] . Our analytic approach did not enable assessment of absolute MR severity in relation to LV perfusion pattern. However, it is unlikely that our grading system would have disproportionately affected MR assessment in relation to a specific perfusion territory so as to bias our results. Second, dedicated viability imaging was not performed as part of the protocol, and thus it remains uncertain as to whether fixed defects in our cohort represent infarction or a profoundly ischemic (i.e. hibernating) myocardium. The latter is suggested by the fact that perfusion defect size was associated with ischemic MR independent of a clinically documented history of MI, suggesting the possibility that at least some fixed perfusion defects may have represented hibernating myocardium. Third, as timing of post-PCI echo was based on the discretion of the treating clinicians, follow-up duration was not standardized. On the other hand, our results demonstrate that inferior fixed perfusion defects were associated with increased MR, independent of follow-up duration, suggesting that variability in follow-up interval did not bias the study results. With regard to follow-up, an additional limitation concerns the fact that post-PCI echo was only available in 52% of patients with MR [63% with advanced ( ≥ moderate) MR]; thus, loss to follow-up could have impacted our findings. Importantly, patients with and without follow-up were similar with respect to perfusion pattern and LV remodeling indices, consistent with the notion that our results are broadly generalizable with respect to the impact of perfusion pattern on MR response to PCI.
Conclusion
This study demonstrates that myocardial perfusion pattern not only influences the severity of ischemic MR but also impacts its response to PCI. Future studies are warranted to test whether MPI can be used to guide therapeutic strategies to treat MR, toward the goal of identifying those patients in whom MR can be effectively treated with coronary revascularization alone.
